# A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.

> **NCT03191201** · PHASE4 · TERMINATED · sponsor: **Prof Gérard WAEBER** · enrollment: 32 (actual)

## Conditions studied

- Iron-deficiency
- Iron Toxicity
- Glucose Metabolism Disorders (Including Diabetes Mellitus)
- Metabolic Side Effects of Drugs
- Metabolic Disorder, Glucose
- Safety Issues

## Interventions

- **DRUG:** Ferric Carboxymaltose
- **DRUG:** 0.9% sodium chloride solution

## Key facts

- **NCT ID:** NCT03191201
- **Lead sponsor:** Prof Gérard WAEBER
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-21
- **Primary completion:** 2020-03-09
- **Final completion:** 2020-03-09
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** The reason for early termination is difficulties recruiting that caused a premature ending of financial resources ensuring protected time for research.
- **Last updated:** 2020-03-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03191201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03191201, "A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03191201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*